Entity

Time filter

Source Type

Yamaguchi, Japan

Yamaguchi University is a national university in Yamaguchi Prefecture, Japan. It has campuses at the cities of Yamaguchi and Ube. Wikipedia.


Patent
Yamaguchi University | Date: 2014-01-14

A device and a method of facing target sputtering are provided, which can easily change magnetic flux line patterns between facing targets, thereby enabling to conveniently perform a plurality of kinds of sputtering such as facing target sputtering with facing mode, facing target sputtering with mixed mode composed of facing mode and magnetron mode. Thus, the device and the method of facing target sputtering effective for each material is provided. The sputtering device for forming a thin film in which a pair of target holders


Patent
Kuraray Co. and Yamaguchi University | Date: 2015-04-08

Provided is a cation exchange membrane having a stable ion exchange performance during usage, being excellent in basic properties such as membrane resistance and ion transportation as well as strength, and useful for electrodialysis and a method for producing the same. The cation exchange membrane is composed of a polyvinyl alcohol copolymer including an anionic group-containing anionic polymer segment and a vinyl alcohol polymer segment, and having a microphase separation structure having a domain size (X) in a range from 0 nm


Patent
Yamaguchi University | Date: 2013-11-07

The present invention addresses the problem of providing a novel therapeutic agent for keratoconjunctive disorders. As a means for solving the problem, a therapeutic agent for keratoconjunctive disorders which contains a RAR agonist as an active ingredient is provided. The therapeutic agent exhibits an excellent ameliorating effect in a keratoconjunctive disorder model, and is therefore useful as a therapeutic agent for keratoconjunctive disorders such as corneal ulcer, corneal epithelial abrasion, keratitis, dry eye, conjunctivitis, chronic superficial keratitis, corneal erosion, persistent corneal disorders, superficial punctate keratopathy, corneal epithelial defects, conjunctival epithelial defects, keratoconjunctivitis sicca, superior limbic keratoconjunctivitis, filamentary keratoconjunctivitis, infectious keratitis, noninfectious keratitis, infectious conjunctivitis and noninfectious conjunctivitis. The therapeutic agent is also useful as a therapeutic agent for corneal scarring and conjunctival scarring both associated with keratoconjunctive disorders.


Patent
Kuraray Co. and Yamaguchi University | Date: 2015-06-23

Provided is an ion exchange membrane including an ionic vinyl alcohol polymer having a cation exchange group or an anion exchange group. The ion exchange membrane


Patent
Ajinomoto Co. and Yamaguchi University | Date: 2014-05-29

The present invention relates to an agent for reducing the side effects of kinase inhibitors, the agent containing at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof as an active ingredient, and also relates to an anticancer medicine containing at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof, and a kinase inhibitor.

Discover hidden collaborations